113 results on '"Emery, P"'
Search Results
2. Impact of a guaranteed annual income program on Canadian seniors’ physical, mental and functional health
3. Genetic and Environmental Variation in Lung Function Drives Subsequent Variation in Aging of Fluid Intelligence
4. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma
5. Evaluation of Finger Ultrasound in the Assessment of Bone Status with Application of Rheumatoid Arthritis
6. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
7. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
8. The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy
9. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
10. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
11. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level
12. Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy
13. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
14. Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
15. Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study
16. Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
17. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence
18. MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib
19. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
20. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
21. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
22. Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe
23. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus
24. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
25. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
26. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
27. The optimal assessment of the rheumatoid arthritis hindfoot: a comparative study of clinical examination, ultrasound and high field MRI
28. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-[kappa]B) transcription factor activation in patients with tumour necrosis factor receptor asssociated periodic syndrome (TRAPS)
29. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
30. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis
31. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
32. Local and systemic glucocorticoid metabolism in inflammatory arthritis
33. Can ultrasonography improve on radiographic assessment in osteoarthritis of the hands? A comparison between radiographic and ultrasonographic detected pathology
34. Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse
35. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
36. Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment
37. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
38. Consensus statement on the use of rituximab in patients with rheumatoid arthritis
39. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
40. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis
41. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
42. Combined high-resolution magnetic resonance imaging and histological examination to explore the role of ligaments and tendons in the phenotypic expression of early hand osteoarthritis
43. Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis
44. Ultrasonography for rheumatologists: the development of specific competency based educational outcomes
45. EULAR report on the use of ultrasonography in painful knee osteoarthritis
46. EULAR report on the use of ultrasonography in painful knee osteoarthritis
47. Updated consensus statement on biological agents, specifically tumour necrosis factor (alpha) (TNF(alpha)) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
48. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
49. The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint
50. Pitfalls in scoring MR images of rheumatoid arthritis wrist and metacarpophalangeal joints
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.